Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
08/2012
08/02/2012WO2012101239A1 Derivatives of azaindazole or diazaindazole type as medicament
08/02/2012WO2012101197A1 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
08/02/2012WO2012101068A1 Novel tetrahydroquinoline derivatives
08/02/2012WO2012100342A1 Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators
08/02/2012WO2012075048A3 Hybrid cyclic libraries and screens thereof
08/02/2012WO2011113802A3 Imidazopyridine and purine compounds, compositions and methods of use
08/02/2012US20120197027 Quinazoline Derivatives as Angiogenesis Inhibitors
08/02/2012US20120197016 Screening methods of modulating adrenergic receptor gene expressions implicated in melanogenesis
08/02/2012US20120196880 Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
08/02/2012US20120196872 New 5-alkynyl-pyridines
08/02/2012US20120196869 Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
08/02/2012US20120196866 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
08/02/2012US20120196856 Aryl aminopyridine pde10 inhibitors
08/02/2012US20120196854 Pharmaceutical composition comprising aromatic heterocyclic compound
08/02/2012US20120196847 6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors
08/02/2012US20120196845 Quinolinone-pyrazolone m1 receptor positive allosteric modulators
08/02/2012US20120195887 Inhibitor Compounds and Cancer Treatment Methods
08/02/2012DE102011009961A1 7-Azaindolderivate 7-azaindole derivatives
08/02/2012DE102011003315A1 New 1H-pyrazolo(3,4-b)pyridine compounds are guanylate cyclase stimulators useful for treating and/or preventing e.g. heart failure, angina pectoris, hypertonia, pulmonary hypertonia, ischemia, vascular disease, and fibrotic disorder
08/02/2012CA2825746A1 Pyrazolopyridine derivative or pharmacologically acceptable salt thereof
08/02/2012CA2825098A1 Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators
08/02/2012CA2824679A1 Pharmaceutical composition comprising pyridone derivatives
08/02/2012CA2824536A1 Protease activated receptor 2 (par2) antagonists
08/02/2012CA2824467A1 Pharmaceutical composition comprising pyridone derivatives
08/02/2012CA2823824A1 Derivatives of azaindazole or diazaindazole type as medicament
08/02/2012CA2823804A1 Novel tetrahydroquinoline derivatives
08/02/2012CA2822120A1 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
08/01/2012EP2481735A1 Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials
08/01/2012EP2481729A1 Nintrogen-containing bicyclic heteroaryl compounds for the treatment of RAF protein kinase-mediated diseases
08/01/2012EP2480549A1 Fused imidazo [3, 2 - d]pyrazines as pi3 kinase inhibitors
08/01/2012EP2480548A2 Indolizine inhibitors of 5-lipoxygenase
08/01/2012EP2480547A2 Indolizine inhibitors of 5-lipoxygenase
08/01/2012EP2480546A1 Imidazopyridine or imidazopyrimidine derivatives as phosphodiesterase 10a inhibitors
08/01/2012EP2480545A1 Fused triazole amines as p2x7 modulators
08/01/2012EP2480253A1 Adsorption of immunopotentiators to insoluble metal salts
08/01/2012EP2480081A1 Bridged heterocyclic compounds and methods of use
08/01/2012EP2480078A1 Pyrido[4,3-b]indoles and methods of use
08/01/2012EP2242757B1 Pyrazolopyridines as kinase inhibitors
08/01/2012EP2235013B1 Substituted tetrahydroimidazopyridine compounds and the use thereof in pharmaceuticals
08/01/2012EP2209784B1 Compounds for the treatment of hepatitis c
08/01/2012EP2173750B1 Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
08/01/2012EP2032535B1 Spirocyclic nitriles as protease inhibitors
08/01/2012EP1971604B1 Pyrrolo-pyridine derivatives for the treatment of cancer diseases
08/01/2012EP1932833B1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
08/01/2012EP1819697B1 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors
08/01/2012EP1794159B1 7-azaindoles and their use as ppar agonists
08/01/2012EP1708701B1 Modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
08/01/2012EP1585757B1 Peptide deformylase inhibitors
08/01/2012CN1918137B Tetrazole compounds and their use as metabotropic glutamate receptor antagonists
08/01/2012CN102625807A 4-substituted pyridin-3-yl-carboxamide compounds and methods of use
08/01/2012CN102625806A Novel organic electroluminescent compounds and organic electroluminescent device using the same
08/01/2012CN102625799A Heterocyclic compounds and their uses
08/01/2012CN102617622A Method for preparing moxifloxacin or its medicinal salt and its intermediate
08/01/2012CN102617578A Imidazole derivative and medicine application thereof
08/01/2012CN102617575A Preparation process of high-purity oxymatrine
08/01/2012CN102617574A Methods and compositions for preparing noribogaine from voacangine
08/01/2012CN102617573A 9-substituted triazole para-naphthalimide derivative, preparation method thereof and application
08/01/2012CN102617572A Tetracene-5,6:11,12-tetrabasic carboxylic acid diimide compound and preparation method thereof
08/01/2012CN102617571A Novel pyridazine compound and use thereof
08/01/2012CN102617570A Preparation method of 1,2-dihydroisoquinoline compound of pyrazole ring
08/01/2012CN102617569A Beta-carboline derivative having antitumor activity and preparation method thereof
08/01/2012CN102617568A Stable moxifloxacin hydrochloride compound and preparation method thereof
08/01/2012CN102617567A Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
08/01/2012CN102617566A Pyrazolo alkylimidazole derivative
08/01/2012CN102617554A Two-photon fluorescent probe taking naphthaline as matrix as well as preparation method and application thereof
08/01/2012CN102617548A Bicycloheteroaryl compounds as GPR Receptor stimulant, compositions and application thereof
08/01/2012CN102206215B Chiral compound
08/01/2012CN102086468B Compound for preventing and treating human papillomavirus infectious diseases and screening method thereof
08/01/2012CN101880278B One-step method for synthesizing 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline
08/01/2012CN101501033B Novel compound having affinity for amyloid
07/2012
07/31/2012US8232401 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
07/31/2012US8232376 Azo compound and method of preparing the azo compound
07/31/2012US8232291 Heterocyclic aromatic compounds useful as growth hormone secretagogues
07/31/2012US8232283 Raf inhibitors
07/31/2012CA2539909C 1,1,1-trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo(2,3-c) pyridin-2-ylmethyl) pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and diabetes
07/26/2012WO2012099451A1 Curcumin compounds containing indolizine and their preparations thereof
07/26/2012WO2012099129A1 Compound having anti-cancer activity
07/26/2012WO2012098849A1 Compound having pyridoindole ring structure and substituted bipyridyl group, and organic electroluminescent element
07/26/2012WO2012098416A1 Diarylacetylene hydrazide containing tyrosine kinase inhibitors
07/26/2012WO2012098132A1 Novel 4-amino-n-hydroxy-benzamides as hdac inhibitors for the treatment of cancer
07/26/2012WO2012098066A1 1,6- and 1,8-naphthyridines useful as dyrk1 inhibitors
07/26/2012WO2012098065A1 Pyrido pyrimidines for use as dyrk1 inhibitors
07/26/2012WO2012098033A1 Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases
07/26/2012WO2012097684A1 Bicyclic carboxamide inhibitors of kinases
07/26/2012WO2012097683A1 Bicyclic inhibitors of alk
07/26/2012WO2012097682A1 Bicyclic inhibitors of alk
07/26/2012WO2012097479A1 Bicyclic inhibitors of anaphastic lymphoma kinase
07/26/2012WO2012075492A3 Carbocycle-substituted purine and 7-deazapurine compounds
07/26/2012WO2011097946A8 Oxazolidinone compounds containing ring-fused bicyclic ring, preparation method and use thereof
07/26/2012US20120190853 Benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
07/26/2012US20120190707 Selective inhibitors of akt and methods of using same
07/26/2012US20120190703 Salts of 13a-(s)desoxytylophorinine, preparation methods and pharmaceutical compositions and uses thereof
07/26/2012US20120190700 Novel 4-amino-n-hydroxy-benzamides for the treatment of cancer
07/26/2012US20120190688 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/26/2012US20120190666 Heteroaryl Compounds as PIKK Inhibitors
07/26/2012US20120190654 Novel bicyclic urea compounds
07/26/2012US20120189646 Novel compounds
07/26/2012US20120189614 Inhibitors of filovirus entry into host cells
07/26/2012US20120189539 Bcl-2/bcl-xl inhibitors and therapeutic methods using the same
07/26/2012US20120189537 Nitrile derivatives and their pharmaceutical use and compositions
1 ... 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 ... 646